Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Renal Insufficiency 1 Neoplasms, Plasma Cell 1 Myasthenia Gravis 1 Multiple Myeloma 1 Liver Cirrhosis 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 13 pembrolizumab 9 Specimen Handling 9 enfortumab vedotin 8 Cisplatin 8 Magnetic Resonance Spectroscopy 7 avelumab 5 Carboplatin 5 vinflunine 4 Nivolumab 4 atezolizumab 3 Immunoglobulin G 3 Disulfides 3 Biopsy 3 eribulin 2 cabozantinib 2 Standard of Care 2 Ramucirumab 2 Radiotherapy 2 Platinum 2 Nephroureterectomy 2 Ipilimumab 2 Doxorubicin 2 Docetaxel 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tremelimumab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Plasmapheresis × Clear all

NCT07087860 2026-05-08

RECIPE-B1

Mayo Clinic

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡